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Abstract
The purpose of this study was to achieve consensus amongst a global panel of expert bariatric surgeons on various aspects of
resuming Bariatric and Metabolic Surgery (BMS) during the Coronavirus Disease-2019 (COVID-19) pandemic. A modified
Delphi consensus-building protocol was used to build consensus amongst 44 globally recognised bariatric surgeons. The experts
were asked to either agree or disagree with 111 statements they collectively proposed over two separate rounds. An agreement
amongst ≥ 70.0% of experts was construed as consensus as per the predetermined methodology. We present here 38 of our key
recommendations. This first global consensus statement on the resumption of BMS can provide a framework for multidisciplin-
ary BMS teams planning to resume local services as well as guide future research in this area.
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Introduction
Though many countries now appear to be past their
Coronavirus Disease-2019 (COVID-19) peak, the world is
still very much in the midst of a pandemic with tens of thou-
sands of new cases being reported globally every day. Not
only that the World Health Organisation has also warned that
the Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) virus, the causative agent of COVID-19,
“may never go away” [1].
Multidisciplinary teams involved in the delivery of
Bariatric and Metabolic Surgery (BMS) are trying to find
ways to resume their services safely especially because there
are expressed concerns that the COVID-19 pandemic might
further aggravate the ongoing obesity pandemic [2]. Several
guidelines have been published recently [3, 4] on how to safe-
ly resume BMS, but there is currently no global consensus on
its various aspects.
Modified Delphi methodology for achieving consensus in
areas of poor evidence and disagreements amongst profes-
sionals is now firmly rooted in clinical medicine including
BMS [5–8]. They are recognised to be more robust and
cheaper compared with consensus building in an open room
setting. The purpose of this study was to achieve consensus
amongst a global panel of expert bariatric surgeons on various
aspects of resuming BMS during the COVID-19 era using a
modified Delphi methodology.
Methods
We constituted a committee of 44 recognised opinion-makers
in the field of BMS from 23 countries. These professionals are
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recognised leaders in the field and include the current, the
incumbent, and several past presidents of the International
Federation for the Surgery of Obesity and Metabolic
Disorders (IFSO); presidents or other office-bearers of many
national obesity surgery societies; andmany others recognised
for academic excellence in the field. Sjaak Pouwels and Islam
Omar were non-voting committee members.
The committee members collectively proposed a total of
111 statements to vote on in two separate rounds after discus-
sions amongst themselves. The word “must” was used to sug-
gest an essential requirement whereas “should” suggested a
desirable requirement. The phrase “initial phase” indicated a
period of 3 months upon resumption of BMS in that centre.
The members were asked to either agree or disagree with each
statement. Following other published consensus papers [5–8],
an agreement amongst ≥ 70.0% of experts was construed as
consensus. Voting was conducted virtually on Typeform®,
and no attempt was made to identify individual members’
responses.
The first-round voting link was made live on 23May 2020,
and the second-round voting was concluded on 1 June 2020.
The committee voted on 88 statements in the first round. In the
second round, the committee voted on only those statements
where there was an agreement/disagreement of ≥ 60.0% but
not enough to reach the consensus threshold of 70.0%. The
committee did not vote again on statements with an
Table 1 Key consensus points in general and facility-specific considerations
Serial
no.
Statements Final voting results
1. A delayed elective BMS hinders the resolution of obesity and its co-morbidities. Agree 100%
(N = 44)
2. The decision to resume BMS must be tailored to the local circumstances. Agree 100%
(N = 44)
3. Fellowship training requirements (caseload) should be altered during the pandemic. Agree 75% (N = 33)
4. All-cause and COVID-19-specific morbidity and mortality of BMS must be closely monitored in the initial phase
(first 3 months after resumption).
Agree 97.7%
(N = 43)
5. The decision to resume BMS must be reviewed monthly by every institution that routinely performed BMS before the
pandemic.
Agree 97.7%
(N = 43)
6. Hospital’s provisions for Personal Protective Equipment (PPE) must be ensured,
and there should be clear policies on how and when to use which type of PPE.
Agree 100%
(N = 44)
7. If a separate hospital/clinic is not available, BMS should be carried out on a hospital wing or part,
which does not treat patients with Coronavirus Disease-19 (COVID-19).
Agree 100%
(N = 44)
8. Screening tests for SARS-CoV-2 should be performed in a designated facility where contact with other patients is
minimised.
Agree 100%
(N = 44)
Table 2 Key consensus points in patient- and staff-specific testing and isolation considerations
Serial
no.
Statements Final voting results
1. Patients should undergo locally appropriate testing to screen for SARS-Cov-2 infection 24–72 h before BMS. Agree 84.1%
(N = 37)
2. Patients must be screened for the symptoms of COVID-19, before arrival into the hospital. Agree 93.2%
(N = 41)
3. Patients’ hospitalisation time before BMS should be as short as possible. Agree 100%
(N = 44)
4. Patients must consent for the potential risk of acquiring SARS-CoV-2 infection during the hospital stay. Agree 93.2%
(N = 41)
5. Patients must not have had any contact with a SARS-CoV-2 positive patient in the fortnight leading up to the operation. Agree 95.5%
(N = 42)
6. BMS must be postponed if the preoperative COVID-19 antigen/ PCR test is positive. Agree 100%
(N = 44)
7. Healthcare professionals (involved in delivering BMS) with symptoms suggestive of COVID-19 must self-isolate for
14 days.
Agree 79.5%
(N = 35)
8. Healthcare professionals with symptoms suggestive of COVID-19 must be tested for SARS-Cov-2 infection before
resuming work.
Agree 97.7%
(N = 43)
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agreement/disagreement of < 60.0% in the first round, as pre-
vious consensus-building exercises have shown that these
statements rarely achieve consensus even after the second
round of voting [5, 6]. The committee also introduced 23
new statements in the second round to further clarify some
of the statements voted on in the first round.
Results
Forty-four globally recognised BMS experts from 23 coun-
tries voted on 111 statements on resuming bariatric practice in
COVID-19 times. The committee achieved consensus on 72/
88 statements voted on in the first round and 14/26 in the
second round. Three statements were voted on again in the
second round as per our methodology. None of these reached
a consensus even after the second round of voting. The com-
mittee also added 23 new statements in the second round for
further clarification of some of the aspects. In total, a consen-
sus was achieved for 86 statements.Table 1 presents the results
of voting on key general and facility-specific considerations.
Amongst the important ones, there was a consensus of 97.7%
on close monitoring of all-cause and COVID-19-specific mor-
bidity and mortality of BMS in the initial phase after resump-
tion; and with 100% consensus that if a separate hospital/
clinic was not available, BMS should be carried out on a
hospital wing or part, which does not treat patients with
COVID-19.
Table 2 presents the voting results on key patient and staff
testing/isolation considerations. Amongst the important ones
in this category, the committee agreed with 84.1% consensus
that patients should undergo locally appropriate testing to
Table 3 Key consensus points in patient selection considerations
Serial
no.
Statements Final voting
results
1. Qualifying criteria for BMS should be the same as before COVID. Agree 88.6%
(N = 39)
2. The choice of the BMS procedure for an individual patient should not be influenced by the COVID-19 pandemic. Agree 86.4%
(N = 38)
3. Patients’ co-morbidities must be carefully optimised before BMS. Agree 100%
(N = 44)
4. Revisional surgery for complication management must not be delayed. Agree 93.2%
(N = 41)
5. Patients with poorer cardio-pulmonary reserves (such as ischemic heart disease and COPD) should be avoided in the initial
phase (first 3 months after resumption).
Agree 72.7%
(N = 32)
6. Patients with > 2 co-morbidities should be avoided in the initial phase (first 3 months after resumption). Agree 86.4%
(N = 38)
7. Policy regarding routine preoperative endoscopy should be the same as before the COVID-19 pandemic. Agree 77.3%
(N = 33)
Table 4 Key consensus points in operative considerations
Serial
no.
Statements Final voting results
1. BMS must be performed laparoscopically or robotically. Agree 86.4%
(N = 38)
2. Surgeons should allow more time for each patient whilst planning their operating theatre schedule. Agree 90.9%
(N = 40)
3. There should be a minimum number of people present in the operating room. Agree 95.5%
(N = 42)
4. Surgical teams should wear the full PPE including an FFP3 or N-95 mask when operating on a COVID-positive
patient.
Agree 100% (N = 44)
5. Fully trained bariatric surgeons should perform the operations during the initial phase. Agree 90.9%
(N = 40)
6. Surgeons should take care to avoid gas leakage during and especially at the end of the operation. Agree 93.2%
(N = 41)
7. The surgeon should use a closed system to remove pneumoperitoneum at the end of the case Agree 81.8%
(N = 36)
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screen for SARS-CoV-2 infection 24–72 h before BMS; and
with 97.7% consensus that healthcare professionals with
symptoms suggestive of COVID-19 must be tested for
SARS-CoV-2 infection before resuming work.
Table 3 presents the voting results on key patient selection
considerations. There was a consensus of 88.6% that qualify-
ing criteria for BMS should be the same as before COVID-19
pandemic; and 86.4% consensus that those with > 2 co-
morbidities should be avoided in the initial phase.
Table 4 presents the voting results on key operative con-
siderations. There was an 86.4% consensus that BMS must be
performed laparoscopically or robotically and 100% consen-
sus that surgical teams should wear the full PPE including an
FFP3 or N-95 mask when operating on a COVID-positive
patient.
Table 5 presents the voting results on key postoperative
considerations. There was 81.8% consensus that patients
should self-isolate with family members at home for approx-
imately 2 weeks after surgery and 95.5% consensus that pa-
tients should undergo a telephonic follow-up within a week of
discharge.
Discussion
This study represents the first multinational effort at achieving
consensus amongst a group of globally recognised BMS ex-
perts on resuming bariatric surgery during the COVID-19
pandemic. The committee achieved a consensus on 86 state-
ments they collectively proposed.
IFSO recently issued guidance advising postponement of
all elective surgical and endoscopic BMS procedures during
the pandemic [9]. However, it is not clear if and when this
pandemic will end.
Furthermore, there are concerns that the COVID-19 pan-
demic may exacerbate the obesity crisis further [2] and some
evidence that patients suffering from obesity may have worse
outcomes with COVID-19. All these factors have led to a
widespread recognition that BMS teams will have to find a
way of resuming this surgery whilst the world is still in the
middle of this pandemic. However, that task has proved diffi-
cult because of the scarce evidence base on the SARS-CoV-2
virus and COVID-19.
Expert advice is often the only tool for clinicians to base
their decisions on in areas where robust evidence is lacking.
At the same time, experts can also have differences amongst
themselves. This makes a consensus amongst experts very
useful for routine decision-making whilst the evidence catches
up to inform practice. Consensus statements are recognised to
be useful for identifying the most pragmatic course of action
in areas of a poor evidence base. Modified Delphi consensus-
building strategies are known to be more robust than tradition-
al consensus-building approaches, which can often be
hijacked by loud voices, and have been successfully used
before in a multitude of clinical settings [5, 6]
Rubino et al. [10] recently argued that patients with the
greatest risk of morbidity and mortality from their disease
should be prioritised in a resource-constrained environment
in terms of availability of BMS. Significantly, and in contrast
to Rubino et al. [10], our committee recommended avoiding
patients with > 2 co-morbidities in the initial phase with an
86.4% consensus. The committee also recommended (72.7%)
avoiding patients with poorer cardio-pulmonary in the initial
phase. However, similar to Rubino et al., there was no agree-
ment on any BMI cutoff for patient selection.
Several weaknesses of this paper need to be acknowledged.
The choice of experts and the threshold of 70% for consensus
can be considered arbitrary. A consensus agreement of a large
Table 5 Key consensus points in postoperative considerations
Serial
no.
Statements Final voting
results
1. Patients must follow an enhanced recovery after bariatric surgery protocol. Agree 95.5%
(N = 42)
2. If patients develop persistent cough or fever postoperatively, they should be tested for COVID-19. Agree 100%
(N = 44)
3. Patients should self-isolate with family members at home for approximately 2 weeks after surgery. Agree 81.8%
(N = 36)
4. Patients should undergo a telephonic follow-up within a week of discharge. Agree 95.5%
(N = 42)
5. Patients should be asked to seek urgent medical attention if they develop any unusual symptoms such as persistent cough,
fever, diarrhoea or vomiting.
Agree 100%
(N = 44)
6. Patients should have easy and fast access to a medical team. Agree 100%
(N = 44)
7. Telemedicine should replace face-to-face consultation as much as possible. Agree 90.9%
(N = 40)
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number of experts is better quality evidence than the opinion
of a single expert. But it is still an opinion that should ideally
be confirmed in adequately designed studies. At the same
time, one has to recognise that evidence on many of the as-
pects concerning the safe resumption of any elective surgery,
let alone BMS, may take months—if not years—to develop.
Conclusion
In this first global attempt at consensus building on the re-
sumption of BMS in COVID-19 times, 44 experts from 23
countries achieved consensus on a number of its aspects.
These can provide a framework for BMS multidisciplinary
teams working on local guidance as well as guide future re-
search in this area.
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